Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Lerer

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Biological Psychiatry|July 20, 2005
Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair familiesSibylle G Schwab, Barbara Hoefgen, Claudia Hanses, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 8, 2007
Genome-wide linkage scan, fine mapping, and haplotype analysis in a large, inbred, Arab Israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13Omri Teltsh, Kyra Kanyas, Osnat Karni, et al.
Molecular Metabolism|August 1, 2025
DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolismDotan Moskovich, Daniel Beilinson, Amit Rosemarin, et al.
International Clinical Psychopharmacology|December 19, 2008
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studiesGeorge I Papakostas, Rena Cooper-Kazaz, Bente C Appelhof, et al.
Psychiatric Genetics|August 12, 2005
II. Serotonin receptor gene polymorphisms and their association with tardive dyskinesia among schizophrenia patients from North IndiaSmita N Deshpande, Panchami G Varma, Prachi Semwal, et al.
Psychopharmacology|September 28, 2011
Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patientsLior Greenbaum, Robert C Smith, Mordechai Lorberboym, et al.
Journal of Affective Disorders|December 10, 2008
Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronineRena Cooper-Kazaz, Wendy M van der Deure, Marco Medici, et al.
Frontiers in Aging Neuroscience|July 4, 2017
Differentially Severe Cognitive Effects of Compromised Cerebral Blood Flow in Aged Mice: Association with Myelin Degradation and Microglia ActivationGilly Wolf, Amit Lotan, Tzuri Lifschytz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 29, 2011
Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sampleAnna Alkelai, Sara Lupoli, Lior Greenbaum, et al.
American Journal of Human Genetics|December 11, 2002
Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad familiesSibylle G Schwab, Michael Knapp, Stephanie Mondabon, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Biological Psychiatry|July 20, 2005
Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair familiesSibylle G Schwab, Barbara Hoefgen, Claudia Hanses, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 8, 2007
Genome-wide linkage scan, fine mapping, and haplotype analysis in a large, inbred, Arab Israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13Omri Teltsh, Kyra Kanyas, Osnat Karni, et al.
Molecular Metabolism|August 1, 2025
DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolismDotan Moskovich, Daniel Beilinson, Amit Rosemarin, et al.
International Clinical Psychopharmacology|December 19, 2008
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studiesGeorge I Papakostas, Rena Cooper-Kazaz, Bente C Appelhof, et al.
Psychiatric Genetics|August 12, 2005
II. Serotonin receptor gene polymorphisms and their association with tardive dyskinesia among schizophrenia patients from North IndiaSmita N Deshpande, Panchami G Varma, Prachi Semwal, et al.
Psychopharmacology|September 28, 2011
Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patientsLior Greenbaum, Robert C Smith, Mordechai Lorberboym, et al.
Journal of Affective Disorders|December 10, 2008
Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronineRena Cooper-Kazaz, Wendy M van der Deure, Marco Medici, et al.
Frontiers in Aging Neuroscience|July 4, 2017
Differentially Severe Cognitive Effects of Compromised Cerebral Blood Flow in Aged Mice: Association with Myelin Degradation and Microglia ActivationGilly Wolf, Amit Lotan, Tzuri Lifschytz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 29, 2011
Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sampleAnna Alkelai, Sara Lupoli, Lior Greenbaum, et al.
American Journal of Human Genetics|December 11, 2002
Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad familiesSibylle G Schwab, Michael Knapp, Stephanie Mondabon, et al.
Pageof 15